Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Incidence of Kaposi Sarcoma in Sweden is Decreasing

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Staphylococcus aureus Augments Release of Matrix Metalloproteinase-8 from Human Polymorpho-nuclear Leukocytes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Skin Microbiome in Atopic Dermatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Measurements of sun sensitivity in five European countries confirm the relative nature of Fitzpatrick skin phototype scale

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Visual scales are superior to questionnaires in skin phototype self-assessment by children

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Skin phototype assessment- certainties and uncertainties

    Research output: Book/ReportPh.D. thesis

  4. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Kaposi sarcoma is a rare skin cancer, and epidemiological research into Kaposi sarcoma is therefore scarce. The current epidemiological situation for Kaposi sarcoma in Sweden is unknown. The authors hypothesized that the incidence of Kaposi sarcoma should have decreased after the introduction of antiretroviral therapy in 1996. Using data from the Swedish Cancer Registry, this study aimed to determine the incidence rates and survival for Kaposi sarcoma in Sweden from 1993 to 2016. The results showed that a total of 657 patients (74.0% men, 26.0% women) were diagnosed with Kaposi sarcoma in Sweden during 1993 to 2016. The overall incidence per 100,000, age-standardized to the world population, decreased from 0.40 to 0.10 (p = 0.003) for both sexes combined, from 0.76 to 0.14 (p=0.003) for men, and from 0.07 to 0.06 (p = 0.86) for women. The 10-year overall survival rate was significantly lower for the study population (30%) compared with the age- and sex-matched Swedish population (56%) (p < 0.00001). Over the study period, incidence rates of Kaposi sarcoma decreased significantly in men, especially during the late 1990s.

Original languageEnglish
JournalActa Dermato-Venereologica
Volume100
Issue number17
Pages (from-to)adv00305
ISSN0001-5555
DOIs
Publication statusPublished - 28 Oct 2020

ID: 61843725